微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00853 微创医疗

未开盘 07-21 16:08:06

7.050

+0.050

+0.71%

最高7.140	最低6.830	成交量965.15万
今开7.000	昨收7.000	日振幅4.43%
总市值135.15亿	流通市值135.15亿	总股本19.17亿
成交额6,759万	换手率0.50%	流通股本19.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00853","market":"HK","secType":"STK","nameCN":"微创医疗","latestPrice":7.05,"timestamp":1784621286002,"preClose":7,"halted":0,"volume":9651518,"delay":0,"changeRate":0.0071428571428571175,"floatShares":1917000000,"shares":1917000000,"eps":-1.0067751952573634,"marketStatus":"未开盘","change":0.05,"latestTime":"07-21 16:08:06","open":7,"high":7.14,"low":6.83,"amount":67586659,"amplitude":0.044286,"askPrice":7.07,"askSize":4100,"bidPrice":7.05,"bidSize":60500,"shortable":3,"etf":0,"ttmEps":1.5448072519682572,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784683800000},"marketStatusCode":0,"adr":0,"listingDate":1285257600000,"exchange":"SEHK","adjPreClose":7,"openAndCloseTimeList":[[1784597400000,1784606400000],[1784610000000,1784620800000]],"volumeRatio":0.5221613769325802,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00853/tweets","defaultTab":"tweets","newsList":[{"id":"1173559762","title":"异动解读｜微创医疗盘中上涨5.11%，出售骨科业务引发市场分歧后股价修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1173559762","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173559762?lang=zh_cn&edition=full","pubTime":"2026-07-20 15:06","pubTimestamp":1784531183,"startTime":"0","endTime":"0","summary":"7月20日，微创医疗盘中上涨5.11%，报7.0港元，成交额9925.51万港元。消息面上，公司7月15日公告旗下苏州微创骨科拟向天智航出售上海微创骨科82.29%股权，对价以天智航发行新股方式支付。此前该消息公布后市场分歧加剧，股价于7月17日大跌逾6%。当前反弹或反映市场对剥离亏损板块、聚焦核心业务逻辑的重新认可。上海微创骨科主营美日欧髋膝关节重建业务，代表产品内轴膝全球累计植入超100万例，但该业务近年持续承压，剥离后有望改善集团利润率。交易仍处筹划阶段，存在不确定性。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122317060","title":"异动解读｜微创医疗盘中下跌6.74%，出售骨科业务引发市场分歧加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1122317060","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122317060?lang=zh_cn&edition=full","pubTime":"2026-07-17 14:02","pubTimestamp":1784268154,"startTime":"0","endTime":"0","summary":"7月17日，微创医疗盘中下跌6.74%，报6.64港元，成交额1.17亿港元。消息面上，公司7月15日公告旗下苏州微创骨科与天智航签署意向书，拟出售上海微创骨科82.29%股权，对价以天智航发行新股方式支付。市场在初期利好消化后分歧加剧：一方面，出售核心海外资产或反映公司偿债压力及半年报业绩承压；另一方面，天智航作为尚未盈利的科创板企业，其换股对价的实际变现能力存在不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"微创医疗出售骨科业务引发市场分歧加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652785473","title":"【券商聚焦】中信建投：建议关注Q2医疗设备高增长公司配置机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2652785473","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652785473?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:56","pubTimestamp":1784249774,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，板块26Q1业绩整体承压。医疗设备预计Q2招标偏弱，部分企业新品及海外驱动增长；医疗器械上游部分公司收入有望高增长；高值耗材受医疗合规要求提升影响，部分企业预计增长良好；IVD低基数下增速有望改善；家用器械部分企业有望延续高增长；医疗服务边际有所回暖。建议关注Q2高增长公司的配置机会，建议关注国产替代向中高端延伸，看好出海、新科技（AI、脑机接口）及并购整合等新技术落地。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU0287142896.SGD","BK1591","00853","BK1247","BK1615","BK0276","BK1617","02235","BK1161","BK1610","LU0173614495.USD","BK1585","BK1501","BK1593","BK1502","BK1571","BK1515","BK1584","01302","02252","06826","601066","00241","BK1583","159873","BK1600","BK1589","BK1222","01066","09996","BK1189","02190","BK1142","BK1574","KCE","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651418372","title":"港股异动 | 微创医疗(00853.HK)涨超6% 天智航拟收购上海微创骨科医疗控股权益 加速布局海外骨科一体化市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2651418372","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651418372?lang=zh_cn&edition=full","pubTime":"2026-07-16 11:31","pubTimestamp":1784172677,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00853","BK1589","BK1100","BK1585","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651652469","title":"重大资产重组！天智航拟购买上海骨科控股权，7月16日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2651652469","media":"北京商报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651652469?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:58","pubTimestamp":1784123927,"startTime":"0","endTime":"0","summary":"北京商报讯（记者董亮王悦彤）7月15日晚间，天智航（688277）披露公告称，公司正在筹划以发行股份的方式购买上海微创骨科医疗科技有限公司（以下简称“上海骨科”）的控股权，同时拟募集配套资金（以下简称“本次交易”）。公司股票将于7月16日开市起停牌，预计停牌时间不超过5个交易日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153807768683.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807768683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","00853","BK1589","BK1583","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161781920","title":"微创医疗：天智航医疗技术以发行新股方式支付对价","url":"https://stock-news.laohu8.com/highlight/detail?id=1161781920","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161781920?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:34","pubTimestamp":1784122464,"startTime":"0","endTime":"0","summary":"微创医疗科学公司宣布，相关交易对价将通过天智航医疗技术公司发行新股的方式完成支付。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1100","00853","BK1585","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651465248","title":"微创医疗(00853)：天智航(688277.SH)拟收购上海微创骨科医疗控股权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2651465248","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651465248?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:03","pubTimestamp":1784120630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗 公布，于2026年7月15日，公司附属公司苏州微创骨科学(集团)有限公司与北京天智航医疗科技股份有限公司(天智航)订立意向书，内容有关天智航可能向苏州微创及上海微创骨科医疗科技有限公司其他股东收购目标公司的控股权益，代价将以天智航发行新股的方式支付。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","BK1583","BK1100","BK1585","159891","00853","688277","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196454725","title":"微创医疗子公司等签署意向书 拟处置上海微创骨科控股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1196454725","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196454725?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:03","pubTimestamp":1784120605,"startTime":"0","endTime":"0","summary":"微创医疗旗下子公司及其他相关方，已就处置其所持有的上海微创骨科有限公司控股权事宜，签署了一份意向书。此举标志着相关方在调整资产组合与优化业务结构方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","00853","BK1589","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185510759","title":"微创医疗（00853）披露海外骨科业务潜在股权转让事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1185510759","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185510759?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:01","pubTimestamp":1784120465,"startTime":"0","endTime":"0","summary":"微创医疗7月15日公告称，其附属公司苏州微创骨科科学（集团）有限公司已与北京天智航医疗科技股份有限公司签署意向书，探讨向天智航及目标公司其他股东出售上海微创骨科医疗科技有限公司控股权。交易对价拟以天智航发行新股的方式支付。根据公告，截至意向书签署日，苏州微创持有目标公司82.29%股权，目标公司被纳入微创医疗合并报表范围，负责集团国际（非中国）骨科业务，在美国、日本和欧洲等市场从事髋关节及膝关节重建业务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650897559","title":"微创医疗(00853.HK)遭摩根大通减持598.77万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650897559","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650897559?lang=zh_cn&edition=full","pubTime":"2026-07-09 23:57","pubTimestamp":1783612625,"startTime":"0","endTime":"0","summary":"格隆汇2月7日丨根据联交所最新权益披露资料显示，2025年2月3日，微创医疗(00853.HK)遭JPMorgan Chase & Co.以每股均价6.3936港元减持好仓598.77万股，涉资约3828.33万港元。\r\n\r\n　　减持后，JPMorgan Chase & Co.最新持好仓数目为160,998,898股，持好仓比例由9.04%下降至8.71%。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/09/20260709895357.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/09/20260709895357.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260709/32303536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00853","BK4585","IE00BN8TJ469.HKD","LU0149725797.USD","FNCL","LU1162221912.USD","LU1145028129.USD","LU1267930490.SGD","LU0868494617.USD","FTXO","IE00B1BXHZ80.USD","IYG","LU2242649171.HKD","PGF","LU0211331839.USD","LU0251132253.USD","LU1551013342.USD","LU1629891620.HKD","IE00B3S45H60.SGD","LU0683600562.USD","BK4566","IXG","IYF","UYG","JPX","LU0820561818.USD","LU2023250330.USD","LU2237443622.USD","IE00BHPRN162.USD","LU1261432733.SGD","LU0964807845.USD","BK1589","BK4207","LU2054465674.USD","KBWB","LU1084165304.USD","LU1116320737.USD","JPO","LU2237443895.HKD","LU1116320901.HKD","VFH","XLF","IE0034235303.USD","LU1720051017.SGD","BK4534","LU2264538146.SGD","IE00BJTD4V19.USD","IE00BJLML261.HKD","LU2505996509.AUD","JPMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292500","title":"小摩减持微创医疗(00853.HK)约74.56万股 每股作价6.7024港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292500","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650292500?lang=zh_cn&edition=full","pubTime":"2026-07-09 18:59","pubTimestamp":1783594783,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00853","BK1100","BK1589","BK1583","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108231289","title":"微创医疗更新6月股份变动月报，股本小幅增加7,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1108231289","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108231289?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:45","pubTimestamp":1783327521,"startTime":"0","endTime":"0","summary":"微创医疗于2026年7月6日发布2026年6月股份变动月报，报告期为2026年6月1日至6月30日。公告显示，公司法定注册股本维持在5,000,000,000股，合计USD 50,000，与上月底持平。截至6月底，已发行股份从上月底的1,917,379,655股增加至1,917,386,655股，增加部分为7,000股。本月内未发生股份回购或注销，库存股份数维持为0股。截至本月底，公司确认仍符合香港联交所主板上市规则有关公众持股量的要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647355287","title":"微创医疗(00853)：陈英耀获选举为公司独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2647355287","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647355287?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:20","pubTimestamp":1782829240,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)发布公告，自股东周年大会结束后，陈英耀博士获选举为公司独立非执行董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461598.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1589","BK1583","00853","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644732297","title":"【券商聚焦】中信建投：建议2026年加配医疗器械板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2644732297","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644732297?lang=zh_cn&edition=full","pubTime":"2026-06-18 09:24","pubTimestamp":1781745845,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券建议，2026年加配医疗器械板块，短期来看，建议把握2026年业绩改善个股的业绩和估值修复机会，多家医疗器械行业细分赛道龙头公司将于2026年迎来加速增长，同时建议关注手术机器人、脑机接口等新科技方向，相关技术突破和商业化落地有望持续催化板块热度。长期来看，医疗器械板块投资机会来自创新、出海和并购整合，板块的创新和国际化能力得到认可，估值正在重构。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984058","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","LU0287142896.SGD","00241","601066","BK1584","BK1593","BK1161","BK1600","02235","BK1574","BK1189","BK1615","00853","02190","BK1587","BK1571","BK1502","01302","LU0173614495.USD","BK1617","BK1142","02252","BK1100","BK1610","BK1501","BK1247","BK0276","BK1222","BK1583","01066","159883","HK0000165453.HKD","09996","BK1591","BK1515","BK1585","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152260464","title":"微创医疗拟回购不超过已发行股本10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1152260464","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152260464?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:52","pubTimestamp":1780908752,"startTime":"0","endTime":"0","summary":"微创医疗发布公告称，根据董事会建议，公司拟向股东周年大会申请授权回购不超过其于股东周年大会当日已发行股份总数10%的股份，约合191,737,965股。该回购将遵循相关上市规则及开曼群岛法例的规定，并使用合法的内部资金进行。公告显示，在2025年5月至2026年6月期间，微创医疗在香港联交所的股价最高为每股16.28港元，最低为每股6.48港元。董事会认为，本次回购安排有利于公司长远发展，亦符合公司及股东的最佳利益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微创医疗拟回购不超过已发行股本10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171478227","title":"微创医疗更新2026年5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171478227","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171478227?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:21","pubTimestamp":1780572093,"startTime":"0","endTime":"0","summary":"微创医疗科学有限公司于2026年6月4日发布截至2026年5月31日的股份变动月报表。公告显示，法定注册股本维持在5,000,000,000股，面值每股USD 0.00001，总额50,000美元无变化。公告显示，本月内没有进行股份购回或注销。截至2026年5月31日，微创医疗科学有限公司总股本为1,917,379,655股。公司声明已遵守香港联合交易所有限公司的上市规则及相关法律规定，上述月报表由公司秘书杨兆琳签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103651928","title":"异动解读｜微创医疗盘中下跌5.12%，大摩大幅下调目标价叠加行业整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1103651928","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103651928?lang=zh_cn&edition=full","pubTime":"2026-05-28 13:05","pubTimestamp":1779944755,"startTime":"0","endTime":"0","summary":"5月28日，微创医疗盘中下跌5.12%，报7.42港元/股，成交额7826.82万港元。消息面上，摩根士丹利近日发布研报，将微创医疗目标价由16港元大幅下调至10.5港元，控股公司折价从30%提高至45%，主要原因为流动性放缓及行业情绪低迷。该行指出，管理层指引上半年仅录得低单位数增长，且受中东冲突影响，介入及骨科产品海外交付出现中断。此外，医疗保健设备板块整体走弱，微创机器人-B跌4.14%、爱康医疗跌4.29%、先健科技跌3.87%，行业性抛压加剧个股跌幅。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637386553","title":"大摩：降微创医疗(00853)目标价至10.5港元 维持“与大市同步”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2637386553","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637386553?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:42","pubTimestamp":1779352927,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，在上海进行中国医疗保健行业调研期间与微创医疗管理层会面。维持微创医疗“与大市同步”评级，由于流动性放缓及行业情绪低迷，控股公司折价从30%提高至45%，目标价由16港元降至10.5港元。报告指，管理层指引2026上半年录得低单位数增长，主要受库存清理及销售代表政策带来温和；并重申2026全年高单位数增长目标。受近期中东冲突影响，微创医疗的介入及骨科产品海外交付出现中断。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444482.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636780823","title":"微创医疗(00853)授出合共50万份购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2636780823","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636780823?lang=zh_cn&edition=full","pubTime":"2026-05-20 22:28","pubTimestamp":1779287286,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)发布公告，集团董事会按公司于2023年6月19日采纳得股份计划向集团1名合资格参与者授出合共50万份购股权，以供认购最多合共50万股每股面值0.00001美元得公司普通股，占公司于本公告日期已发行股本约0.03%，惟须待承授人接纳购股权后，方可作实。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1583","BK1585","BK1100","00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197585556","title":"微创医疗更新2026年4月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1197585556","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197585556?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:37","pubTimestamp":1778143033,"startTime":"0","endTime":"0","summary":"微创医疗科学有限公司于2026年5月7日发布截至2026年4月30日的证券变动月报。根据公告，法定/注册股本维持在5,000,000,000股普通股，对应注册资本USD 50,000，未发生任何变动。公告显示，截至2026年4月30日，公司已发行普通股总数为1,917,372,655股，较上月底未发生变化。该月并无通过行使期权新增发行股份。公司指出，截至本月末股本总数保持稳定，并确认遵守香港联交所《上市规则》及其他适用法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microport.com.cn","stockEarnings":[{"period":"1week","weight":0.0602},{"period":"1month","weight":0.0666},{"period":"3month","weight":-0.2337},{"period":"6month","weight":-0.4342},{"period":"1year","weight":-0.1444},{"period":"ytd","weight":-0.3484}],"compareEarnings":[{"period":"1week","weight":0.0325},{"period":"1month","weight":0.0505},{"period":"3month","weight":-0.0394},{"period":"6month","weight":-0.0562},{"period":"1year","weight":0.0055},{"period":"ytd","weight":-0.0194}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大动脉及外周血管介入业务分部包括“L-REBOA”主动脉阻断球囊等产品。神经介入业务分部包括脑动脉粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009025},{"month":2,"riseRate":0.4375,"avgChangeRate":0.009312},{"month":3,"riseRate":0.5,"avgChangeRate":0.015172},{"month":4,"riseRate":0.375,"avgChangeRate":0.012111},{"month":5,"riseRate":0.5625,"avgChangeRate":0.020952},{"month":6,"riseRate":0.4375,"avgChangeRate":0.033969},{"month":7,"riseRate":0.5625,"avgChangeRate":0.036844},{"month":8,"riseRate":0.266667,"avgChangeRate":-0.055578},{"month":9,"riseRate":0.6,"avgChangeRate":0.032463},{"month":10,"riseRate":0.625,"avgChangeRate":0.009684},{"month":11,"riseRate":0.4375,"avgChangeRate":0.005167},{"month":12,"riseRate":0.375,"avgChangeRate":-0.015138}],"exchange":"SEHK","name":"微创医疗","nameEN":"MICROPORT"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创医疗,00853,微创医疗股票,微创医疗股票老虎,微创医疗股票老虎国际,微创医疗行情,微创医疗股票行情,微创医疗股价,微创医疗股市,微创医疗股票价格,微创医疗股票交易,微创医疗股票购买,微创医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}